TrialReach is a groundbreaking website that helps patients with any medical condition to explore, understand and access the latest clinical trials, anywhere in the world. The internet and social media have enabled patients to become much more deeply involved in managing their own diseases and there has been an explosion of online information. However, the information about new treatments and clinical trials has remained, until now, obscure and inaccessible for the majority of those patients looking online for help. At the same time, every day, thousands of new patients are needed in projects designed to prove the effectiveness of new medical treatments and devices. TrialReach’s unique website combines a specialised search engine, exclusive patient-friendly information and fast communication channels between patients and physicians to make clinical trials easy to find, easy to understand, and easy to access.

Alex van Someren, General Partner in the Amadeus & Angels Seed Fund, said: 'I was impressed from the outset by the importance of what TrialReach does in quickly connecting patients with treatments which could help them. Even better, the company was founded by a team with real experience in building successful technology businesses. I’m genuinely excited about the potential for TrialReach to improve people’s lives, save trial sponsors time & money, and build a global business for our investors.’

Alex van Someren is Amadeus' representative on the Board of TrialReach

To watch TrialReach's video about what they do, click on the link

http://blog.trialreach.com/2011/11/08/watch-our-new-how-it-works-video